Seoul National University College of Veterinary Medicine Prof. Baek Seung-joon's team announces results of 3-month clinical trial of KID-T in cats
Administration of 'KID-T' to cats with chronic renal failure over a 3-month period showed decreases in blood ammonia, blood urea nitrogen, creatinine levels, and urine protein-to-creatinine ratio. This suggests it could be highly beneficial for treating renal failure in dogs and cats in the future.
KID-T is a natural herb-based therapeutic product originally developed to treat human renal failure and is registered with the US FDA NDC (equivalent to over-the-counter drugs in Korea) for 'kidney function recovery.'
The Seoul National University College of Veterinary Medicine Integrative Veterinary Medicine Center announced on the 10th that their paper on 'Clinical Trial of KID-T Administration Effects in Cats with Chronic Renal Failure' was published in a recent issue of the international journal 'Veterinary Integrative Science' under the title 'KID-T, a unique polyherbal extract, improves feline patients with azotemia and uremia.'
This study was conducted at Seoul National University College of Veterinary Medicine at the request of Herb Medipharm (formerly Petcell Bio), the developer of KID-T. The research team explained that throughout the study period, clinical and biochemical examinations confirmed a gradual stabilization of severely impaired kidney function.
Changes in blood and urine test results in cats administered KID-T over 3 months
"Through this clinical trial in cats with chronic renal failure, we confirmed that KID-T can improve and maintain kidney function in feline renal failure patients with azotemia and uremia, and it also showed effects in preventing complications caused by renal failure," said Prof. Baek Seung-joon of Seoul National University College of Veterinary Medicine. "We expect it to be greatly helpful in treating renal failure in dogs and cats in the future."
"While treating renal failure in animals through this clinical trial was meaningful, what was particularly significant from a veterinary perspective was observing cats that had been suffering from cystitis and azotemia for months gradually show improvement in cystitis, azotemia, and hyperammonemia after taking KID-T for 2-4 weeks," said Prof. Oh Won-seok (also Director of Oh Won-seok Hwanggeum Animal Hospital), who co-conducted the research. "We expect KID-T could become a new option as an adjunctive therapy for renal failure treatment."
"KID-T is a product with long-proven safety and efficacy in humans, and we plan to launch it in the market as an adjunctive treatment for companion animal renal failure in the near future," said a Herb Medipharm representative.
Renal failure and kidney disease are among the most common diseases in cats worldwide and one of the leading causes of death. Since kidney damage is particularly difficult to reverse once it occurs, the results of this animal clinical trial of a natural herb-based renal failure treatment product conducted at Seoul National University College of Veterinary Medicine are significant in demonstrating considerable potential for integrative veterinary medicine and natural product-based therapies in future renal failure treatment.
"We are discussing with the company about conducting additional large-scale clinical trials to study the potential benefits of KID-T, such as evaluating quality of life in feline renal failure patients and guardian satisfaction," Prof. Baek added.
Source: MK Health (Medical Correspondent Lee Byung-moon)
Seoul National University College of Veterinary Medicine Prof. Baek Seung-joon's team announces results of 3-month clinical trial of KID-T in cats
Administration of 'KID-T' to cats with chronic renal failure over a 3-month period showed decreases in blood ammonia, blood urea nitrogen, creatinine levels, and urine protein-to-creatinine ratio. This suggests it could be highly beneficial for treating renal failure in dogs and cats in the future.
KID-T is a natural herb-based therapeutic product originally developed to treat human renal failure and is registered with the US FDA NDC (equivalent to over-the-counter drugs in Korea) for 'kidney function recovery.'
The Seoul National University College of Veterinary Medicine Integrative Veterinary Medicine Center announced on the 10th that their paper on 'Clinical Trial of KID-T Administration Effects in Cats with Chronic Renal Failure' was published in a recent issue of the international journal 'Veterinary Integrative Science' under the title 'KID-T, a unique polyherbal extract, improves feline patients with azotemia and uremia.'
This study was conducted at Seoul National University College of Veterinary Medicine at the request of Herb Medipharm (formerly Petcell Bio), the developer of KID-T. The research team explained that throughout the study period, clinical and biochemical examinations confirmed a gradual stabilization of severely impaired kidney function.
"Through this clinical trial in cats with chronic renal failure, we confirmed that KID-T can improve and maintain kidney function in feline renal failure patients with azotemia and uremia, and it also showed effects in preventing complications caused by renal failure," said Prof. Baek Seung-joon of Seoul National University College of Veterinary Medicine. "We expect it to be greatly helpful in treating renal failure in dogs and cats in the future."
"While treating renal failure in animals through this clinical trial was meaningful, what was particularly significant from a veterinary perspective was observing cats that had been suffering from cystitis and azotemia for months gradually show improvement in cystitis, azotemia, and hyperammonemia after taking KID-T for 2-4 weeks," said Prof. Oh Won-seok (also Director of Oh Won-seok Hwanggeum Animal Hospital), who co-conducted the research. "We expect KID-T could become a new option as an adjunctive therapy for renal failure treatment."
"KID-T is a product with long-proven safety and efficacy in humans, and we plan to launch it in the market as an adjunctive treatment for companion animal renal failure in the near future," said a Herb Medipharm representative.
Renal failure and kidney disease are among the most common diseases in cats worldwide and one of the leading causes of death. Since kidney damage is particularly difficult to reverse once it occurs, the results of this animal clinical trial of a natural herb-based renal failure treatment product conducted at Seoul National University College of Veterinary Medicine are significant in demonstrating considerable potential for integrative veterinary medicine and natural product-based therapies in future renal failure treatment.
"We are discussing with the company about conducting additional large-scale clinical trials to study the potential benefits of KID-T, such as evaluating quality of life in feline renal failure patients and guardian satisfaction," Prof. Baek added.
Source: MK Health (Medical Correspondent Lee Byung-moon)